scholarly journals Reproducibility of Molecular Phenotypes after Long-Term Differentiation to Human iPSC-Derived Neurons: A Multi-Site Omics Study

2018 ◽  
Vol 11 (4) ◽  
pp. 897-911 ◽  
Author(s):  
Viola Volpato ◽  
James Smith ◽  
Cynthia Sandor ◽  
Janina S. Ried ◽  
Anna Baud ◽  
...  
EBioMedicine ◽  
2019 ◽  
Vol 39 ◽  
pp. 562-574 ◽  
Author(s):  
Hung-Ya Tu ◽  
Takehito Watanabe ◽  
Hiroshi Shirai ◽  
Suguru Yamasaki ◽  
Masaharu Kinoshita ◽  
...  

2020 ◽  
Author(s):  
Shadi Zabad ◽  
Alan M Moses

AbstractWe study the evolution of quantitative molecular traits in the absence of selection. Using a simple theory based on Felsenstein’s 1981 DNA substitution model, we predict a linear restoring force on the mean of an additive phenotype. Remarkably, the mean dynamics are independent of the effect sizes and genotype and are similar to the widely-used OU model for stabilizing selection. We confirm the predictions empirically using additive molecular phenotypes calculated from ancestral reconstructions of putatively unconstrained DNA sequences in primate genomes. We show that the OU model is favoured by inference software even when applied to GC content of unconstrained sequences or simulations of DNA evolution. We predict and confirm empirically that the dynamics of the variance are more complicated than those predicted by the OU model, and show that our results for the restoring force of mutation hold even for non-additive phenotypes, such as number of transcription factor binding sites, longest encoded peptide and folding propensity of the encoded peptide. Our results have implications for efforts to infer selection based on quantitative phenotype dynamics as well as to understand long-term trends in evolution of quantitative molecular traits.


iScience ◽  
2021 ◽  
Vol 24 (4) ◽  
pp. 102309
Author(s):  
Fumisato Ozawa ◽  
Shogo Nagata ◽  
Haruka Oda ◽  
Shigeharu G. Yabe ◽  
Hitoshi Okochi ◽  
...  
Keyword(s):  
Β Cells ◽  

2017 ◽  
Vol 88 ◽  
pp. 237-238
Author(s):  
Liang Guo ◽  
Michael Furniss ◽  
Jodie Mussio ◽  
John Hamre ◽  
Sandy Eldridge ◽  
...  
Keyword(s):  

Cells ◽  
2021 ◽  
Vol 10 (9) ◽  
pp. 2263
Author(s):  
Agata Barzowska ◽  
Barbara Pucelik ◽  
Katarzyna Pustelny ◽  
Alex Matsuda ◽  
Alicja Martyniak ◽  
...  

The rising prevalence of diabetes is threatening global health. It is known not only for the occurrence of severe complications but also for the SARS-Cov-2 pandemic, which shows that it exacerbates susceptibility to infections. Current therapies focus on artificially maintaining insulin homeostasis, and a durable cure has not yet been achieved. We demonstrate that our set of small molecule inhibitors of DYRK1A kinase potently promotes β-cell proliferation, enhances long-term insulin secretion, and balances glucagon level in the organoid model of the human islets. Comparable activity is seen in INS-1E and MIN6 cells, in isolated mice islets, and human iPSC-derived β-cells. Our compounds exert a significantly more pronounced effect compared to harmine, the best-documented molecule enhancing β-cell proliferation. Using a body-like environment of the organoid, we provide a proof-of-concept that small–molecule–induced human β-cell proliferation via DYRK1A inhibition is achievable, which lends a considerable promise for regenerative medicine in T1DM and T2DM treatment.


Author(s):  
Juan A. Pérez-Bermejo ◽  
Serah Kang ◽  
Sarah J. Rockwood ◽  
Camille R. Simoneau ◽  
David A. Joy ◽  
...  

ABSTRACTAlthough COVID-19 causes cardiac dysfunction in up to 25% of patients, its pathogenesis remains unclear. Exposure of human iPSC-derived heart cells to SARS-CoV-2 revealed productive infection and robust transcriptomic and morphological signatures of damage, particularly in cardiomyocytes. Transcriptomic disruption of structural proteins corroborated adverse morphologic features, which included a distinct pattern of myofibrillar fragmentation and numerous iPSC-cardiomyocytes lacking nuclear DNA. Human autopsy specimens from COVID-19 patients displayed similar sarcomeric disruption, as well as cardiomyocytes without DNA staining. These striking cytopathic features provide new insights into SARS-CoV-2 induced cardiac damage, offer a platform for discovery of potential therapeutics, and raise serious concerns about the long-term consequences of COVID-19.


2019 ◽  
Author(s):  
Estela Cruvinel ◽  
Isabella Ogusuku ◽  
Rosanna Cerioni ◽  
Jéssica Gonçalves ◽  
Maria Elisa Góes ◽  
...  

ABSTRACTObjectivesTo validate a straightforward single-cell passaging cultivation method that enables high-quality maintenance of hiPSC without the appearance of karyotypic abnormalities or loss of pluripotency.MethodsCells were kept in culture for over 50 passages, following a structured chronogram of passage and monitoring cell growth by population doubling time (PDT) calculation and cell confluence. Standard procedures for iPSC monitoring as embryonic body (EB) formation, karyotyping and pluripotency markers expression were evaluated in order to monitor the cellular state in the long-term culture. Cells that underwent these tests were then subjected to differentiation into keratinocytes and cardiomyocytes to evaluate its differentiation capacity.ResultshiPSC clones maintained its pluripotent capability as well as chromosomal integrity and were able to generate derivatives from the three germ layers at high passages by embryoid body formation and high-efficient direct differentiation into keratinocytes and cardiomyocytes.ConclusionOur findings support the routine of hiPSC single-cell passaging as a reliable procedure even after long-term cultivation, providing healthy PSCs to be used in drugs discovery, toxicity and disease modeling as well as for therapeutic approaches.


2020 ◽  
Vol 461 (1) ◽  
pp. 86-95 ◽  
Author(s):  
Rosa D’Alessio ◽  
Fani Koukouli ◽  
Stéphane Blanchard ◽  
Julie Catteau ◽  
Célia Raïs ◽  
...  

2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Reina Bassil ◽  
Kenneth Shields ◽  
Kevin Granger ◽  
Ivan Zein ◽  
Shirley Ng ◽  
...  

AbstractAdvancement in human induced pluripotent stem cell (iPSC) neuron and microglial differentiation protocols allow for disease modeling using physiologically relevant cells. However, iPSC differentiation and culturing protocols have posed challenges to maintaining consistency. Here, we generated an automated, consistent, and long-term culturing platform of human iPSC neurons, astrocytes, and microglia. Using this platform we generated a iPSC AD model using human derived cells, which showed signs of Aβ plaques, dystrophic neurites around plaques, synapse loss, dendrite retraction, axon fragmentation, phospho-Tau induction, and neuronal cell death in one model. We showed that the human iPSC microglia internalized and compacted Aβ to generate and surround the plaques, thereby conferring some neuroprotection. We investigated the mechanism of action of anti-Aβ antibodies protection and found that they protected neurons from these pathologies and were most effective before pTau induction. Taken together, these results suggest that this model can facilitate target discovery and drug development efforts.


Sign in / Sign up

Export Citation Format

Share Document